Core Viewpoint - The article highlights the successful transformation of the ancient Chinese medicine Suhexiang Wan by the company Lei Yun Shang into a modern health product, emphasizing its significant market growth and innovative strategies in the healthcare sector [2][5][9]. Group 1: Historical Background and Product Development - Suhexiang Wan's formula dates back to the Tang Dynasty, with its efficacy in treating cardiovascular diseases being recognized for centuries [1][3]. - Lei Yun Shang, established in 1734, has played a crucial role in popularizing Suhexiang Wan, integrating traditional practices with modern medical research [3][4]. - The company has developed a diverse product line in the cardiovascular medicine sector, with Suhexiang Wan standing out due to its unique benefits and market acceptance [3][4]. Group 2: Market Performance and Growth Strategy - According to data from Zhongkang CMH and Mi Nei Wang, Lei Yun Shang's Suhexiang Wan has seen a remarkable retail market sales growth of 236% year-on-year in 2024 [1][4]. - The company has adopted an innovative strategy of empowering retail through collaboration with over 100 pharmacy chains, enhancing sales through academic service systems [4][5]. - The shift in product positioning from "emergency use" to "daily prevention" aligns with contemporary consumer preferences for preventive healthcare [5][9]. Group 3: Quality Control and Research Collaboration - Lei Yun Shang emphasizes the use of high-quality, authentic medicinal materials, establishing a comprehensive traceability system for its products [7][8]. - The company collaborates with prestigious universities and medical institutions to conduct clinical research, enhancing the credibility and efficacy of its products [8][9]. - Efforts to appeal to younger demographics include product innovation in packaging and taste, as well as cross-industry collaborations [8][9].